Related Experiment Video
Updated: May 1, 2026
Use of Cerebral Open-Flow Microperfusion for the Longitudinal Collection of Interstitial Fluid in an Animal Model of Glioblastoma
Published on: December 23, 2025
Cerebral microdialysis in glioma studies, from theory to application
Lin Liu1, Xiangyi Zhang1, Yan Lou1
1The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, China.
Abstract:
Despite recent advances in the treatment of solid tumors, there are few effective treatments for malignant gliomas due to the infiltrative nature, and the protective shield of blood-brain barrier or blood-tumor barriers that restrict the passage of chemotherapy drugs into the brain. Imaging techniques, such as PET and MRI, have allowed the assessment of tumor function in vivo, but they are indirect measures of activity and do not easily allow continuous repeated evaluations. Because the biology of glioma on a cellular and molecular level is fairly unknown, especially in relation to various treatments, the development of novel therapeutic approaches to this devastating condition requires a strong need for a deeper understanding of the tumor's pathophysiology and biochemistry. Cerebral microdialysis, a probe-based sampling technique, allows a discrete volume of the brain to be sampled for neurochemical analysis of neurotransmitters, metabolites, biomarkers, and chemotherapy drugs, which has been employed in studying brain tumors, and is significant for improving the treatment of glioma. In this review, the current concepts of cerebral microdialysis for glioma are elucidated, with a special emphasis on its application to neurochemistry and pharmacokinetic studies.
Insights
Cerebral microdialysis offers a direct method to study glioma pathophysiology and drug delivery, overcoming limitations of current imaging techniques. This technique aids in understanding brain tumor biochemistry for improved malignant glioma treatment.
Area of Science:
- Neuro-oncology
- Neurosurgery
- Pharmacology
Background:
- Malignant gliomas are challenging to treat due to their infiltrative nature and the blood-brain barrier limiting drug penetration.
- Current imaging techniques like PET and MRI provide indirect measures of tumor activity and are not ideal for continuous evaluation.
- A deeper understanding of glioma pathophysiology and biochemistry is crucial for developing novel therapeutic strategies.
Purpose of the Study:
- To review the application of cerebral microdialysis in understanding glioma.
- To elucidate current concepts of cerebral microdialysis for glioma research.
- To emphasize its utility in neurochemical and pharmacokinetic studies for improved glioma treatment.
Main Methods:
- Cerebral microdialysis, a probe-based technique, enables direct sampling of brain tissue.
- Allows in vivo neurochemical analysis of neurotransmitters, metabolites, biomarkers, and chemotherapy drugs within the brain tumor microenvironment.
- Facilitates continuous and repeated evaluations of brain tumor biochemistry and drug pharmacokinetics.
Main Results:
- Cerebral microdialysis provides direct, real-time data on the brain tumor microenvironment.
- Enables detailed analysis of drug concentrations and their distribution within gliomas.
- Offers insights into glioma pathophysiology and response to treatment at a molecular level.
Conclusions:
- Cerebral microdialysis is a valuable tool for advancing glioma research and treatment.
- It overcomes limitations of indirect imaging methods for assessing tumor biochemistry and drug pharmacokinetics.
- This technique holds significant potential for improving therapeutic strategies for malignant gliomas.
